Clover Health Investments Corp (NASDAQ: CLOV)’s stock price has gone decline by -3.68 in comparison to its previous close of 0.82, however, the company has experienced a 1.00% increase in its stock price over the last five trading days. InvestorPlace reported 2024-03-20 that Numbers frequently take center stage in the stock market’s maze. However, every figure has a story of strategy, ingenuity, and resiliency behind it.
Is It Worth Investing in Clover Health Investments Corp (NASDAQ: CLOV) Right Now?
The 36-month beta value for CLOV is at 1.86. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CLOV is 374.90M, and currently, shorts hold a 9.75% of that float. The average trading volume for CLOV on March 26, 2024 was 9.86M shares.
CLOV’s Market Performance
CLOV’s stock has seen a 1.00% increase for the week, with a -12.38% drop in the past month and a -19.29% fall in the past quarter. The volatility ratio for the week is 6.33%, and the volatility levels for the past 30 days are at 6.28% for Clover Health Investments Corp The simple moving average for the last 20 days is -4.16% for CLOV’s stock, with a simple moving average of -22.73% for the last 200 days.
Analysts’ Opinion of CLOV
Many brokerage firms have already submitted their reports for CLOV stocks, with Cowen repeating the rating for CLOV by listing it as a “Market Perform.” The predicted price for CLOV in the upcoming period, according to Cowen is $3 based on the research report published on February 02, 2022 of the previous year 2022.
Canaccord Genuity, on the other hand, stated in their research note that they expect to see CLOV reach a price target of $6. The rating they have provided for CLOV stocks is “Buy” according to the report published on February 02nd, 2022.
SVB Leerink gave a rating of “Mkt Perform” to CLOV, setting the target price at $3 in the report published on January 19th of the previous year.
CLOV Trading at -13.36% from the 50-Day Moving Average
After a stumble in the market that brought CLOV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.47% of loss for the given period.
Volatility was left at 6.28%, however, over the last 30 days, the volatility rate increased by 6.33%, as shares sank -12.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -19.37% lower at present.
During the last 5 trading sessions, CLOV rose by +0.87%, which changed the moving average for the period of 200-days by -21.00% in comparison to the 20-day moving average, which settled at $0.8199. In addition, Clover Health Investments Corp saw -16.92% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLOV starting from Loengard Anna U, who purchase 137,000 shares at the price of $0.73 back on Mar 14 ’24. After this action, Loengard Anna U now owns 538,841 shares of Clover Health Investments Corp, valued at $100,010 using the latest closing price.
Loengard Anna U, the Director of Clover Health Investments Corp, purchase 13,625 shares at $0.73 during a trade that took place back on Mar 14 ’24, which means that Loengard Anna U is holding 15,125 shares at $9,946 based on the most recent closing price.
Stock Fundamentals for CLOV
Current profitability levels for the company are sitting at:
- -0.1 for the present operating margin
- 0.12 for the gross margin
The net margin for Clover Health Investments Corp stands at -0.11. The total capital return value is set at -0.67. Equity return is now at value -67.29, with -30.94 for asset returns.
Based on Clover Health Investments Corp (CLOV), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -24.85. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -29791.71.
Currently, EBITDA for the company is -180.16 million with net debt to EBITDA at 0.65. When we switch over and look at the enterprise to sales, we see a ratio of 0.13. The receivables turnover for the company is 17.82for trailing twelve months and the total asset turnover is 3.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.64.
Conclusion
In conclusion, Clover Health Investments Corp (CLOV) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
